Source comparison
GHRP-2 Acetate Peptide: Research Applications Comparison
Pulsatile GH Release Studies Binds GHS-R1a to trigger endogenous pulsatile secretion matching natural circadian rhythm Recombinant GH (exogenous administration) GHRP-2 preserves physiological pulse pattern; exogenous GH creates sustained non-pulsatile elevatio
This comparison does not assign a generated winner or score.
- Pulsatile GH Release Studies
- Binds GHS-R1a to trigger endogenous pulsatile secretion matching natural circadian rhythm
- Recombinant GH (exogenous administration)
- GHRP-2 preserves physiological pulse pattern; exogenous GH creates sustained non-pulsatile elevation
- GHRP-2 superior for studies requiring intact feedback loops
- IGF-1 Pathway Research
- Stimulates hepatic IGF-1 production via GH-mediated STAT5 signaling
- MK-677 (oral ghrelin mimetic)
- GHRP-2 injectable with 2-hour half-life; MK-677 oral with 24-hour half-life creating sustained rather than pulsatile effect
- GHRP-2 preferred for acute-response studies; MK-677 for chronic elevation models
- Lipolytic Pathway Analysis
- GH pulse triggers hormone-sensitive lipase activation in adipocytes over 4–6 hours post-pulse
- CJC-1295 (GHRH analog)
- GHRP-2 acts on ghrelin pathway; CJC-1295 on GHRH pathway—synergistic when combined
- Combined protocols produce 60–80% greater GH AUC than either alone
- Appetite Regulation Studies
- Weak ghrelin receptor agonism (15–20% of natural ghrelin affinity)
- GHRP-6 (stronger ghrelin agonism)
- GHRP-2 produces minimal appetite stimulation; GHRP-6 significantly increases food intake
- GHRP-2 cleaner choice when isolating GH effects from orexigenic confounds